The Olympus Blog

AI Integrated Wearables for Gut Health Diagnosis: Olympus Innovation Ventures Invests in Alimetry

The clinician-founded team behind Alimetry recently announced the close of their Series A2 round of funding to pursue broad commercialization of their AI-powered, wearable device. The Alimetry device is designed to be used as an aid in the diagnosis of gut disorders that have proven difficult to solve using conventional diagnostics and testing.

Would You Have Performed a Colonoscopy and Polypectomy in This High-risk Patient Following a Major GI Bleed?

“This case demonstrates the evolution of the management of colon polyps in the setting of lower GI bleeding,” states Dr. Meisner.
“How so?” you may ask. To find out, read about how Dr. Meisner addresses the substantial polyps he encounters, why he chose to use the Olympus® SnareMasterTM Plus Snare, and the technique he employed during the procedure.

Seven Reasons Why the HDTV in Your Living Room Should Not Be Used in a Procedure Room

“Most consumer-grade monitors sold today have some kind of network functionality, which presents a major risk to patient safety, as well as a security risk if protected health information (PHI) is accessible outside of hospital IT firewalls on connected devices,” according to Blake Pena, Product Manager for Image Chain and Accessories at Olympus.

A Patient-first Approach to Improve Bladder Control: Olympus Innovation Ventures Invests in Neuspera

Olympus Innovation Ventures (OIV) recently announced a Series D investment in Neuspera Medical, Inc. This move underscores OIV’s commitment to investing in pioneering minimally invasive solutions that have the potential to enhance patient care and quality of life.

White Paper Explores the Need for Ergonomic Guidelines in the GI Endoscopy Suite

On-demand Webinar: IP Goes Deep in Lung Periphery

Interventional Pulmonologist Ali Sadoughi, MD, shares his experience on peripheral airway bronchoscopy and lung disease in this prerecorded webinar.

Study Finds Texture and Color Enhancement Imaging Improves Colonic Adenoma Detection

The results from a 2023 multicenter randomized controlled trial published in Gastroenterology reveal Texture and Color Enhancement Imaging (TXI™) technology, available on the Olympus® EVIS X1™ endoscopy system, significantly improves the adenoma detection rate (ADR) and the rate of adenomas per colonoscopy (APC) ≥5mm in size versus white light endoscopy (WLE),3 highlighting its potential in enhancing the quality of colonoscopy screenings. 

Harvard Gynecologist Reviews Olympus® Contained Tissue Extraction System

In “Guardenia: A ‘Really Great Solution’ for Contained Tissue Extraction,” published on MDedge® by OBG Management, Dr. Greenberg shares his opinion and perspective of the design, functionality, and level of innovation of the Guardenia™ Contained Tissue Extraction System.

Five Things Not Required With This Microdebrider

In the ear, nose, and throat (ENT) practice, the shift to office-based procedures is a growing trend to curtail costs and help improve patient convenience. Becker’s Healthcare spoke with three leading otolaryngologists about this trend, and how Olympus’ single-use CELERISTM microdebrider is answering some previously unmet needs.

Illuminating Cancer Cells During Surgery: A Worthy Olympus Investment

On November 16, 2023, Olympus Innovation Ventures (OIV) announced its participation in the $30M Series C funding round to help West Lafayette, Ind. based On Target Laboratories (OTL). The team is working to accelerate commercialization of their novel compound—used in conjunction with near infrared surgical imaging devices.

Medtech: Boldly Going Where Women Have Not Gone Before

But with representation still under a quarter of medtech leadership roles, organizations like the nonprofit MedExecWomen have emerged to support female leadership in this space. Olympus Corporation was one of the sponsors of its fourth annual conference, “Growing Your Business, Yourself, and Your Leaders,” held May 16, 2023, in Cambridge, MA.

When Little Things are a Big Deal: Olympus’ Investment in Eximis Aims to Keep Incisions Small

"Olympus is excited to support Eximis Surgical in the development of this promising new technology,” said Nacho Abia, Chief Strategy Officer for Olympus Corporation. “Supporting physicians in elevating the standard of care for patients is a priority for Olympus.”